The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Lurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In bipolar it may be used together with a mood stabilizer such as lithium or valproate. It is taken by mouth.
The global Lurasidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Common side effects include sleepiness, movement disorders, nausea, and diarrhea. Serious side effects may include the potentially permanent movement disorder tardive dyskinesia, as well as neuroleptic malignant syndrome, an increased risk of suicide, angioedema, and high blood sugar levels. In older people with psychosis as a result of dementia, it may increase the risk of dying.Use during pregnancy is of unclear safety. How it works is not clear but is believed to involve effects on dopamine and serotonin in the brain.
This report aims to provide a comprehensive presentation of the global market for Lurasidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lurasidone.
Report Scope
The Lurasidone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lurasidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lurasidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Angelini Holding S.p.A.
Sumitomo Dainippon Pharma Co., Ltd.
RemedyRepack，Inc.
Bushu Pharmaceutical, LTD.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Healthcare Pharmaceuticals Limited
Square Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd.
Segment by Type
20mg/tablet
40mg/tablet
60mg/tablet
80mg/tablet
120mg/tablet
Segment by Application
Hospital
Psychological Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lurasidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lurasidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Lurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In bipolar it may be used together with a mood stabilizer such as lithium or valproate. It is taken by mouth.
The global Lurasidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Common side effects include sleepiness, movement disorders, nausea, and diarrhea. Serious side effects may include the potentially permanent movement disorder tardive dyskinesia, as well as neuroleptic malignant syndrome, an increased risk of suicide, angioedema, and high blood sugar levels. In older people with psychosis as a result of dementia, it may increase the risk of dying.Use during pregnancy is of unclear safety. How it works is not clear but is believed to involve effects on dopamine and serotonin in the brain.
This report aims to provide a comprehensive presentation of the global market for Lurasidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lurasidone.
Report Scope
The Lurasidone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lurasidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lurasidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Angelini Holding S.p.A.
Sumitomo Dainippon Pharma Co., Ltd.
RemedyRepack，Inc.
Bushu Pharmaceutical, LTD.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Healthcare Pharmaceuticals Limited
Square Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd.
Segment by Type
20mg/tablet
40mg/tablet
60mg/tablet
80mg/tablet
120mg/tablet
Segment by Application
Hospital
Psychological Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lurasidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lurasidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Lurasidone Market Overview
1.1 Product Overview and Scope of Lurasidone
1.2 Lurasidone Segment by Type
1.2.1 Global Lurasidone Market Value Comparison by Type (2024-2030)
1.2.2 20mg/tablet
1.2.3 40mg/tablet
1.2.4 60mg/tablet
1.2.5 80mg/tablet
1.2.6 120mg/tablet
1.3 Lurasidone Segment by Application
1.3.1 Global Lurasidone Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Psychological Clinic
1.3.4 Others
1.4 Global Lurasidone Market Size Estimates and Forecasts
1.4.1 Global Lurasidone Revenue 2019-2030
1.4.2 Global Lurasidone Sales 2019-2030
1.4.3 Global Lurasidone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lurasidone Market Competition by Manufacturers
2.1 Global Lurasidone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lurasidone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lurasidone Average Price by Manufacturers (2019-2024)
2.4 Global Lurasidone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lurasidone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lurasidone, Product Type & Application
2.7 Lurasidone Market Competitive Situation and Trends
2.7.1 Lurasidone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lurasidone Players Market Share by Revenue
2.7.3 Global Lurasidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lurasidone Retrospective Market Scenario by Region
3.1 Global Lurasidone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lurasidone Global Lurasidone Sales by Region: 2019-2030
3.2.1 Global Lurasidone Sales by Region: 2019-2024
3.2.2 Global Lurasidone Sales by Region: 2025-2030
3.3 Global Lurasidone Global Lurasidone Revenue by Region: 2019-2030
3.3.1 Global Lurasidone Revenue by Region: 2019-2024
3.3.2 Global Lurasidone Revenue by Region: 2025-2030
3.4 North America Lurasidone Market Facts & Figures by Country
3.4.1 North America Lurasidone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lurasidone Sales by Country (2019-2030)
3.4.3 North America Lurasidone Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lurasidone Market Facts & Figures by Country
3.5.1 Europe Lurasidone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lurasidone Sales by Country (2019-2030)
3.5.3 Europe Lurasidone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lurasidone Market Facts & Figures by Country
3.6.1 Asia Pacific Lurasidone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lurasidone Sales by Country (2019-2030)
3.6.3 Asia Pacific Lurasidone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lurasidone Market Facts & Figures by Country
3.7.1 Latin America Lurasidone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lurasidone Sales by Country (2019-2030)
3.7.3 Latin America Lurasidone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Lurasidone Market Facts & Figures by Country
3.8.1 Middle East and Africa Lurasidone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lurasidone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lurasidone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lurasidone Sales by Type (2019-2030)
4.1.1 Global Lurasidone Sales by Type (2019-2024)
4.1.2 Global Lurasidone Sales by Type (2025-2030)
4.1.3 Global Lurasidone Sales Market Share by Type (2019-2030)
4.2 Global Lurasidone Revenue by Type (2019-2030)
4.2.1 Global Lurasidone Revenue by Type (2019-2024)
4.2.2 Global Lurasidone Revenue by Type (2025-2030)
4.2.3 Global Lurasidone Revenue Market Share by Type (2019-2030)
4.3 Global Lurasidone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lurasidone Sales by Application (2019-2030)
5.1.1 Global Lurasidone Sales by Application (2019-2024)
5.1.2 Global Lurasidone Sales by Application (2025-2030)
5.1.3 Global Lurasidone Sales Market Share by Application (2019-2030)
5.2 Global Lurasidone Revenue by Application (2019-2030)
5.2.1 Global Lurasidone Revenue by Application (2019-2024)
5.2.2 Global Lurasidone Revenue by Application (2025-2030)
5.2.3 Global Lurasidone Revenue Market Share by Application (2019-2030)
5.3 Global Lurasidone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Angelini Holding S.p.A.
6.1.1 Angelini Holding S.p.A. Corporation Information
6.1.2 Angelini Holding S.p.A. Description and Business Overview
6.1.3 Angelini Holding S.p.A. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Angelini Holding S.p.A. Lurasidone Product Portfolio
6.1.5 Angelini Holding S.p.A. Recent Developments/Updates
6.2 Sumitomo Dainippon Pharma Co., Ltd.
6.2.1 Sumitomo Dainippon Pharma Co., Ltd. Corporation Information
6.2.2 Sumitomo Dainippon Pharma Co., Ltd. Description and Business Overview
6.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio
6.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments/Updates
6.3 RemedyRepack，Inc.
6.3.1 RemedyRepack，Inc. Corporation Information
6.3.2 RemedyRepack，Inc. Description and Business Overview
6.3.3 RemedyRepack，Inc. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 RemedyRepack，Inc. Lurasidone Product Portfolio
6.3.5 RemedyRepack，Inc. Recent Developments/Updates
6.4 Bushu Pharmaceutical, LTD.
6.4.1 Bushu Pharmaceutical, LTD. Corporation Information
6.4.2 Bushu Pharmaceutical, LTD. Description and Business Overview
6.4.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio
6.4.5 Bushu Pharmaceutical, LTD. Recent Developments/Updates
6.5 Zhejiang Hisun Pharmaceutical Co., Ltd.
6.5.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio
6.5.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Healthcare Pharmaceuticals Limited
6.6.1 Healthcare Pharmaceuticals Limited Corporation Information
6.6.2 Healthcare Pharmaceuticals Limited Description and Business Overview
6.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio
6.6.5 Healthcare Pharmaceuticals Limited Recent Developments/Updates
6.7 Square Pharmaceuticals Ltd.
6.6.1 Square Pharmaceuticals Ltd. Corporation Information
6.6.2 Square Pharmaceuticals Ltd. Description and Business Overview
6.6.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Square Pharmaceuticals Ltd. Lurasidone Product Portfolio
6.7.5 Square Pharmaceuticals Ltd. Recent Developments/Updates
6.8 Incepta Pharmaceuticals Ltd.
6.8.1 Incepta Pharmaceuticals Ltd. Corporation Information
6.8.2 Incepta Pharmaceuticals Ltd. Description and Business Overview
6.8.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio
6.8.5 Incepta Pharmaceuticals Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lurasidone Industry Chain Analysis
7.2 Lurasidone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lurasidone Production Mode & Process
7.4 Lurasidone Sales and Marketing
7.4.1 Lurasidone Sales Channels
7.4.2 Lurasidone Distributors
7.5 Lurasidone Customers
8 Lurasidone Market Dynamics
8.1 Lurasidone Industry Trends
8.2 Lurasidone Market Drivers
8.3 Lurasidone Market Challenges
8.4 Lurasidone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
